A Chronic Lymphocytic Leukemia Patient with Progressive Multifocal Leukoencephalopathy Caused by John Cunningham Virus
Abstract
We present a case of a 67-year-old woman who suffered from CLL with a chief complaint of seizure. Her clinical symptoms, results of brain MRI and biopsy were suggestive for the JCV-induced PML. The patient had received treatment using mefloquine at dose of 250 mg/day with no clinical improvement.
Keywords
References
Montserrat E, Moreno C. Chronic lymphocytic leukemia: a short overview. Ann Oncol. 2008;19:320-36.
Morrison VA. Infectious complications in patients with chronic lymphocytic leukemia, pathogenesis, spectrum of infection and approaches to prophylaxis. Clin Lymph Myeloma. 2009;9:365-70.
Bag AK, Cure JK, Chapman PR, et al. JC virus infection of the brain. Am J Neuroradiol. 2010;31:1564-76.
Shackelton LA, Rambaut A, Pybus O, et al. JC virus evolution and its association with human populations. J Virol. 2006;80:9928-33.
Saribas AS, Ozdemir A, Lam C, et al. JC virus-induced progressive multifocal leukoencephalopathy. Future Virol. 2010;5:313-23.
D’Souza A, Wilson J, Mukherje S, et al. Progressive multifocal leukoencephalopathy in chromic lymphocytic leukemia: A report of three cases and review of the literature. Clin Lymph Myeloma Leukem. 2010;10:E1–E9.
Da Silva RL. Spectrum of neurologic complications in chronic lymphocytic leukemia. Clin Lymph Myeloma Leukem. 2012;12:164-79.
Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med. 2005;352:804-15.
Johnston BJ, Seftel M, Spencer BG. Chronic lymphocytic leukemia. In: editor Greer JP, Foerster J, Rodgers GM, Paraskevas F, Glader B, Arber AD, Means TR, eds. Wintrobe’s clinical hematology. 12th edition. Philadelphia: Lippincott Williams & Wilkins; 2009. p. 2214-45.
Sedana MP. New insight in management of chronic lymphocytic leukemia. Naskah lengkap Surabaya Hematologi Onkologi Medik Update-VIII (Surabaya HOM Update-VIII) medical management of cancer. In: Boediwarsono, Soebandiri, Soegianto, Ashariati A, Sedana MP, Ugroseno, eds. Surabaya; 2009. p. 200-6.
Shanafelt TD, Call TG. Current approach in diagnosis and management of chronic lymphocytic leukemia. Mayo Clin Proc. 2004;79:388-98.
Rotty WL. Leukemia limfositik kronik. In: Sudoyo AW, Setyohadi B, Alwi I, Simadibrata M, Setiati S, eds. Buku ajar ilmu penyakit dalam. 5th edition. Jakarta: Interna Publishing; 2009. p. 1276-81.
Hamblin AD, Hamblin TJ. The immunodeficiency of chronic lymphocytic leukemia. Br Med Bull. 2008;7:49-62.
Bower JH, Hammack JE, McDonnell SK, et al. The neurologic complications of B-cell chronic lymphocytic leukemia. Neurology. 1997;48:407-12.
Jiang M, Abend J, Johnson S, et al. The role of polyomaviruses in human disease. Virology. 2009; 384:266-73.
Monaco M, Atwood W, Gravell M, et al. JC virus infectiojn of hematopoietic progenitor cells, primary B lymphocytes, and tonsillar stromal cells: implications for viral latency. J Virol. 1996;70:7004-12.
Bofill-Mas S, Girones R. Role of the environment in the transmission of JC virus. J Neurovirol. 2003;9:54-8.
Hou J, Seth P, Major E. JC virus can infect human immune and nervous system progenitor cells: implication for pathogenesis. Polyomavirus and human disease advances in experimental medicine and biology. 2005;577:266-73.
La Rose G, Fratini M, Libera S, et al. Emerging and potentially emerging viruses in water environments. Ann Ist Super Sanita. 2012;48:397-406.
Engsig FN, Hansen A, Omland LH, et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: A nationwide cohort study. J Infect Dis. 2009; 199:77-83.
Zhang M, Li F, Rasper M, et al. Prolonged stability of progressive multifocal leukoencephalopathy in a patient with chronic lymphocytic leukemia. J Clin Oncol. 2010;28:e503-e506.
Laubach J. Progressive Multifocal Leukoencephalopathy after therapy for chronic lymphocytic leukemia. Clin Leukem. 2009;3:E24-E26.
Pho MT, Ashok A, Alwood WJ. JC virus enter human glial cells by clathrin-dependent receptor-mediated endocytosis. J Virol. 2000;74:2288-92.
Elphick GF, Querbes W, Jordan JA, et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004;306:1380-3.
Horger M, Beschorner R, Beck R, et al. Common and uncommon imaging findings in progressive multifocal leukonchephalopathy (PML) with differential diagnostic considerations. Clin Neurolog Neurosurg. 2012;114:1123-30.
Hou J, Major E. Progressive multifocal leukoencephalopathy: JC virus induced demyelination in the immune compromised host. J Neuro Virol. 2000; 6:s98-s100.
Calabrese L. A rational approach to PML for the clinician. Cleve Clin J Med. 2011;78:s38-41.
Focosi D, Kast R, Maggi F, et al. Risperidone-induced reduction in JC viruria as a surrogate marker for efficacy against progressive multifocal leukoencephalopathy and hemorrhagic cystitis. J Clin Virol. 2007;39:63-4.
Verma S, Cikurel K, Koralnik I, et al. Mirtazapine in progressive multifocal leukoenchepalopathy associated with polycythemia vera. J Infect Dis. 2007;196:709-11.
Gofton TE, Al-khotanil A, O’Farrell B, et al. Mefloquine in the treatment of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry. 2010;82:452-5.
Clifford DB, Nath A, Cinque P, et al. A study of Mefloquine treatment for progressive multifocal leukoencephalopathy: Result and exploration of predictors of PML outcomes. J Neuro Virol. 2013;19: 351-8.
Pelosini M, Focosi D, Rita F, et al. Progressive multifocal leukoencephalopathy report of three cases in HIV-negative hematological patients and review of literature. Ann Hematol. 2007; DOL 10.1007/S D0277-007-0411-6.
Refbacks
- There are currently no refbacks.
This work is licensed under a